Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 6,266,000 | 9,087,000 | 9,145,000 | 7,687,000 | 6,037,000 |
Marketable Securities | 4,381,000 | 3,273,000 | 2,276,000 | 325,000 | 2,874,000 |
Receivables | 4,525,000 | 4,094,000 | 5,366,000 | 5,009,000 | 4,057,000 |
Inventories | 3,893,000 | 3,942,000 | 3,840,000 | 3,682,000 | 3,584,000 |
Other current assets | 2,079,000 | 2,265,000 | 2,268,000 | 2,110,000 | 1,888,000 |
TOTAL | $21,144,000 | $22,661,000 | $22,895,000 | $18,813,000 | $18,440,000 |
Non-Current Assets | |||||
PPE Net | 4,889,000 | 4,816,000 | 4,843,000 | 4,879,000 | 4,928,000 |
Intangibles | 31,276,000 | 31,928,000 | 32,626,000 | 33,336,000 | 34,116,000 |
Other Non-Current Assets | 5,639,000 | 5,232,000 | 4,647,000 | 4,641,000 | 2,223,000 |
TOTAL | $41,804,000 | $41,976,000 | $42,116,000 | $42,856,000 | $41,267,000 |
Total Assets | $62,948,000 | $64,637,000 | $65,011,000 | $61,669,000 | $59,707,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 91,000 | 91,000 | 91,000 | 1,840,000 | 2,953,000 |
Accounts payable and accrued liabilities | 1,421,000 | 1,161,000 | 1,150,000 | 1,338,000 | 1,371,000 |
Accrued Expenses | 10,141,000 | 8,701,000 | 9,282,000 | 8,649,000 | 8,511,000 |
TOTAL | $11,653,000 | $9,953,000 | $10,523,000 | $11,827,000 | $12,835,000 |
Non-Current Liabilities | |||||
Long Term Debt | 32,895,000 | 34,196,000 | 34,133,000 | 30,008,000 | 26,950,000 |
aiOther Non-Current Liabilities | 8,991,000 | 9,319,000 | 9,437,000 | 9,922,000 | 10,249,000 |
TOTAL | $41,886,000 | $43,725,000 | $43,829,000 | $40,357,000 | $37,199,000 |
Total Liabilities | $53,539,000 | $53,678,000 | $54,352,000 | $52,184,000 | $50,034,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 577,566 | 582,169 | 585,694 | 588,247 | 589,807 |
Common Shares | 31,802,000 | 31,713,000 | 31,610,000 | 31,525,000 | 31,531,000 |
Retained earnings | -21,408,000 | -19,851,000 | -20,168,000 | -21,378,000 | -21,330,000 |
Other shareholders' equity | -985,000 | -903,000 | -783,000 | -662,000 | -528,000 |
TOTAL | $9,409,000 | $10,959,000 | $10,659,000 | $9,485,000 | $9,673,000 |
Total Liabilities And Equity | $62,948,000 | $64,637,000 | $65,011,000 | $61,669,000 | $59,707,000 |